drugset / Trial / NCT00279825
Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
RandomizedCrossoverTriple-blindTreatment
Summary
The objective of this study is to compare the pharmacokinetics and pharmacodynamics of IPX054, carbidopa-levodopa immediate-release tablets, and carbidopa-levodopa controlled-release tablets in subjects with idiopathic Parkinson's disease.
Timeline
- Start
- 2006-01
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD-LD CR | Unknown | 50 mg | — |
| Subject | CD-LD CR | Unknown | 200 mg | — |
| Subject | CD-LD IR | Unknown | 25 mg | — |
| Subject | CD-LD IR | Unknown | 100 mg | — |
| Subject | IPX054 | Unknown | 200 mg | — |
| Subject | IPX054 | Unknown | 250 mg | — |